-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SPv4UfA12EYsVcMxj6htVLgGozRmjFlkzw0RqmygkLZbkw8FED/GsuK5BIvKTr8i B7QgbSe02tBvDfZbSnYdqg== 0000946644-04-000013.txt : 20040715 0000946644-04-000013.hdr.sgml : 20040715 20040715155041 ACCESSION NUMBER: 0000946644-04-000013 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040715 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-108645 FILM NUMBER: 04915847 BUSINESS ADDRESS: STREET 1: 1617 JFK BLVD #660 STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19104 BUSINESS PHONE: 2159880080 MAIL ADDRESS: STREET 1: 1617 JFK BLVD STREET 2: ONE PENN CENTER CITY: PHILADELPHIA STATE: PA ZIP: 19103 424B3 1 r424b3_2.txt Filed Pursuant to Rule 424(b)(3) Registration Nos. 333-108645, 333-111135 and 333-113796 PROSPECTUS SUPPLEMENT Number 2 to Prospectus dated April 9, 2004 of HEMISPHERX BIOPHARMA, INC. On July 13, 2004, the holders of the following securities exercised the securities: (a) warrants that we issued in October 2003 to purchase an aggregate of 410,134 shares of our Common Stock at an exercise price of $2.32 per share (referred to in the prospectus as the "October 2008 Warrants"), (b) warrant that we issued in July 2003 to purchase an aggregate of 507,102 shares of our Common Stock at an exercise price of $2.46 per share (referred to in the prospectus as the "July 2008 Warrants") and (c) additional investment rights that we issued in January 2004 to purchase an aggregate of $2,000,000 in principal amount of 6% senior secured convertible debentures due January 31, 2006 (referred to in the prospectus as the "Additional Investment Rights"). We received gross proceeds of $4,198,980 from the exercise of these securities. We issued to the exercising holders warrants (the "June 2009 Warrants") to purchase an aggregate of 1,300,000 shares of common stock commencing on January 13, 2005 through June 30, 2009 at an initial exercise price of $3.75 per share. The general terms of the June 2009 Warrants are similar to the terms of warrants issued on May 14, 2004 (referred to in Supplement No. 1 to the prospectus as the "May 2009 Warrants"). We have agreed to register the shares issuable upon exercise of the June 2009 Warrants in accordance with terms substantially similar to those in the Registration Rights Agreement dated January 26, 2004. NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS SUPPLEMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE. The date of this Prospectus Supplement is July 15, 2004 -----END PRIVACY-ENHANCED MESSAGE-----